European CBD0 Oil Market Overview
Medical cannabis is termed as plant-derived cannabis products prescribed by a medical expert. Medical cannabis products are manufactured as plant materials, tinctures, oils, edibles or capsules. Medical cannabis is already legal or will be in the short duration i.e. within three years across Europe. Insurance companies in Germany, Israel, Italy, and Denmark are now covering medical cannabis prescriptions, projecting that over the forecast period the medical cannabis prescriptions will become a basic requirement of any public healthcare policy. Thus, accounting that Europe will be the leading medical cannabis market in the world
European CBD0 Oil Market Dynamics
Regulatory Framework on Medical Cannabis
The signs of impending legalization for marijuana’s are increasingly apparently, but there are various norms that must be undertaken to secure a stable foundation for the market. In 2018, after Canada's decision to fully legalize recreational cannabis, the WHO began to review the plant’s legal status. The European Parliament Committee on the Environment, Public Health and Food Safety is working to establish a “region-wide regulatory framework on medical cannabis,” which could lead to multinational regulation. Thus, driving growth of the target market in European region. Moreover, crime reduction, employment opportunities, and potential growth in tax revenue are key boosting forces for the establishment of a legal recreational cannabis market in Europe.
Lack of Clinical Data
Lack of clinical data regarding the benefits of medical marijuana is a retraining factor for the target market, including lack of funding for reliable and effective research. Further, the need for educational programmes is not yet established for medical professionals. Healthcare professionals and Doctors must be knowledgeable and informed as to the benefits and uses of cannabis.
European CBD0 Oil Market Segmentation
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
The European CBD oil market and medical cannabis market is segmented based on source, application, distribution channel, and region.
On the basis of source, the European CBD oil market and medical cannabis market is segmented into hemp and marijuana. Based on application, the target market is segmented into pharmaceuticals, cosmetics & personal care, and food & beverages. On the basis of distribution channel, the target market is classified into hypermarket/supermarket, online retail, sports store, and others
Based on region, the European CBD oil Market and medical cannabis market is segmented into U.K., Germany, Netherlands, Switzerland, Italy, France, Poland, Czech Republic, and Croatia. The Europe has an active hemp market, with production in most member states. Production is centered in the Netherlands, France, Lithuania, and Romania.
Germany has recently completed the legislative reforms required to increase the medical use of cannabis. Currently, it is one of the first countries in the world to allow medical cannabis in the basic range of medications that must be covered by both public health services and private insurers. According to the law passed in 2017, the development also allows domestic production of cannabis – even though for now all cannabis medications are mainly imported from the Netherlands
Switzerland has the legal permission for the sale, possession, and consumption of both legal and recreational CBD with a THC content as high as 1.0 %. Additionally, CBD products are available in tobacco shops for purchase. Therefore, the ease of consumer access and softening of THC limitations makes Switzerland one of the biggest European players within the CBD market.
In the Czech Republic, even though the country passed a law for medical cannabis in 2013, there is no clear procedure for acquiring licenses to produce, sell or purchase products resulting from cannabis. There is uncertainty about the potential and scope of this reform, both for the development of an industry and for the welfare of the patients.
On 1st November 2017, Poland marked the first day on which medicinal cannabis could be sold in registered pharmacies. Patients requires a special permission from a physician accredited by the Ministry of Health and a regional pharmaceutical inspector. The law does not allow domestic production or self-cultivation, it only allows the introduction of cannabis (mainly from the Netherlands)
In 2018, on the basis of sales, Italy ranked second largest for medical cannabis market in Europe. The Ministry of Health, in Italy declared that the country will triple the amount of medical cannabis produced domestically in 2020. Further, the need for imports will still continue due to continues demand for medical cannabis
U.K. is experiencing a lack of integral regulation for medicinal cannabis which leads to hamper access of these medications for thousands of patients. The government has only permitted the use of Sativex for patients suffering from multiple sclerosis, under medical prescription. The public health service in the United Kingdom has also established that every patient should pay for his or her medication, at a cost of about 500 euros a month.
In 2018, The Netherlands accounted for the third-largest medical cannabis market in Europe. The Netherlands is taking steps to drive the country’s medical cannabis cultivation, a move that could end Dutch cultivator Bedrocan’s longstanding monopoly position for supplying the country.
In 2019, a key government committee in France has set the stage for a two-year medical cannabis trial program that is projected to kick off the market growth, providing an opportunity for overseas companies to export product to the new market during its early stages.
|
Attribute |
Details |
|
Base year for estimation |
2019 |
|
Forecast period |
2019 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2019 to 2029 |
|
Market Segmentation |
By Source- Hemp and Marijuana By Application– Pharmaceuticals, Cosmetics & Personal Care, and Food & Beverages By Distribution Channel – Hypermarket/Supermarket, Online Retail, Sports Store, and Others |
|
Regional scope |
U.K., Germany, Netherlands, Switzerland, Italy, France, Poland, Czech Republic, and Croatia |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the European CBD oil Market and Medical Cannabis market report based on source, application, distribution channel, and region:
European CBD oil Market and Medical Cannabis Market, By Source:
- Hemp
- Marijuana
European CBD oil Market and Medical Cannabis Market, By Application:
- Pharmaceuticals
- Cosmetics & Personal Care
- Food & Beverages
European CBD oil Market and Medical Cannabis Market, By Distribution Channel:
- Hypermarket/Supermarket
- Online Retail
- Sports Store
- Others
European CBD oil Market and Medical Cannabis Market, By Region:
- U.K.
- Germany
- Netherlands
- Switzerland
- Italy
- France
- Poland
- Czech Republic
- Croatia
European CBD0 Oil Market Key Players
The key players operating the European CBD oil market and medical cannabis market includes ENDOCA, Isodiol, Medical Marijuana, Aurora Cannabis, CBD American Shaman, Elixinol, Folium Biosciences, IRIE CBD, and NuLeaf Naturals. Companies are also projected to continue to expand their offerings in the European cannabis space. Further many international investors are choosing to acquire European CBD brands in addition to their investments in local cannabis companies.
European CBD0 Oil Market Company Profile
- ENDOCA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Isodiol
- Medical Marijuana
- Aurora Cannabis
- CBD American Shaman
- Elixinol
- Folium Biosciences
- IRIE CBD
- NuLeaf Naturals
“*” marked represents similar segmentation in other categories in the respective section
European CBD0 Oil Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Outlook for CBD oil Market and Medical Cannabis Strategies
- Key Questions this Study will Answer
- Market Snippet, By Source
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- European CBD oil Market and Medical Cannabis Market, By Source, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hemp
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Marijuana
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- European CBD oil Market and Medical Cannabis Market, By Application, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Pharmaceuticals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Cosmetics & Personal Care
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Food & Beverages
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- European CBD oil Market and Medical Cannabis Market, By Distribution Channel, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hypermarket/Supermarket
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Online Retail
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Sports Store
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- European CBD oil Market and Medical Cannabis Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- U.K.
- Germany
- Netherlands
- Switzerland
- Italy
- France
- Poland
- Czech Republic
- Croatia
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- ENDOCA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Isodiol
- Medical Marijuana
- Aurora Cannabis
- CBD American Shaman
- Elixinol
- Folium Biosciences
- IRIE CBD
- NuLeaf Naturals
- ENDOCA
-
- The Last Word
- Future Impact
- About Us
- Contact